Paracoccidioidomycosis Diagnosed in Europe-A Systematic Literature Review.

Paracoccidioides spp. endemic systemic mycosis paracoccidioidomycosis

Journal

Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827

Informations de publication

Date de publication:
23 Feb 2021
Historique:
received: 20 11 2020
revised: 10 02 2021
accepted: 11 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 7 3 2021
Statut: epublish

Résumé

Paracoccidioidomycosis is a systemic mycosis that is endemic in geographical regions of Central and South America. Cases that occur in nonendemic regions of the world are imported through migration and travel. Due to the limited number of cases in Europe, most physicians are not familiar with paracoccidioidomycosis and its close clinical and histopathological resemblance to other infectious and noninfectious disease. To increase awareness of this insidious mycosis, we conducted a systematic review to summarize the evidence on cases diagnosed and reported in Europe. We searched PubMed and Embase to identify cases of paracoccidioidomycosis diagnosed in European countries. In addition, we used Scopus for citation tracking and manually screened bibliographies of relevant articles. We conducted dual abstract and full-text screening of references yielded by our searches. To identify publications published prior to 1985, we used the previously published review by Ajello et al. Overall, we identified 83 cases of paracoccidioidomycosis diagnosed in 11 European countries, published in 68 articles. Age of patients ranged from 24 to 77 years; the majority were male. Time from leaving the endemic region and first occurrence of symptoms considerably varied. Our review illustrates the challenges of considering systemic mycosis in the differential diagnosis of people returning or immigrating to Europe from endemic areas. Travel history is important for diagnostic-workup, though it might be difficult to obtain due to possible long latency period of the disease.

Identifiants

pubmed: 33672212
pii: jof7020157
doi: 10.3390/jof7020157
pmc: PMC7926554
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Internal funds from the Department of Evidence-based Medicine and Evaluation, Danube University Krems, Austria.
ID : .

Références

Lancet. 2004 Apr 17;363(9417):1282
pubmed: 15094273
Prax Klin Pneumol. 1988 Sep;42(9):722-5
pubmed: 3186680
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Med Clin (Barc). 1995 Dec 2;105(19):756
pubmed: 8523959
Actas Dermosifiliogr. 1974 Nov-Dec;65(11-12):509-22
pubmed: 4462372
Br J Dermatol. 2008 Mar;158(3):624-6
pubmed: 18067474
Schweiz Med Wochenschr. 1979 May 5;109(18):693-9
pubmed: 432600
Clin Exp Dermatol. 2010 Aug;35(6):576-80
pubmed: 19874328
Med Mycol. 2002 Apr;40(2):213-6
pubmed: 12058735
J Fungi (Basel). 2017 Jan 03;3(1):
pubmed: 29371520
Rev Iberoam Micol. 2007 Mar;24(1):44-6
pubmed: 17592892
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e18-e20
pubmed: 31407392
Med Mycol Case Rep. 2016 Dec 02;14:12-16
pubmed: 27995053
Eur J Clin Microbiol Infect Dis. 2004 Dec;23(12):916-9
pubmed: 15599655
Infection. 2000 Mar-Apr;28(2):119-20
pubmed: 10782401
Med Mycol. 2006 Feb;44(1):13-8
pubmed: 16805088
J Travel Med. 2011 Jan-Feb;18(1):26-33
pubmed: 21199139
Riforma Med. 1956 Sep 8;70(36):1009-14
pubmed: 13380210
Travel Med Infect Dis. 2018 Mar - Apr;22:80-81
pubmed: 29223364
Mykosen. 1976 Aug;19(8):265-70
pubmed: 967197
Enferm Infecc Microbiol Clin. 2019 Nov;37(9):609-610
pubmed: 31029485
Enferm Infecc Microbiol Clin. 2012 Aug;30(7):407-13
pubmed: 22130575
Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):415-6
pubmed: 23332607
Mycoses. 2003;46(9-10):407-11
pubmed: 14622390
Fungal Genet Biol. 2017 Sep;106:9-25
pubmed: 28602831
Soc Ital Dermatol Sifilogr Sezioni Interprov Soc Ital Dermatol Sifilogr. 1955 Jul-Aug;96(4):321-58
pubmed: 13285711
Radiol Med. 1998 May;95(5):521-3
pubmed: 9687934
Semin Respir Crit Care Med. 2020 Feb;41(1):53-68
pubmed: 32000284
Minerva Dermatol. 1965 Nov;40(11):413-21
pubmed: 5881682
Ann Dermatol Venereol. 2014 Aug-Sep;141(8-9):514-7
pubmed: 25209814
Tidsskr Nor Laegeforen. 2001 Jan 10;121(1):33-4
pubmed: 12013613
Am J Clin Pathol. 1966 Nov;46(5):514-37
pubmed: 5920384
Clin Microbiol Rev. 2011 Apr;24(2):296-313
pubmed: 21482727
Med Mycol. 2018 Nov 1;56(8):950-962
pubmed: 29325170
Hautarzt. 1985 Jul;36(7):408-11
pubmed: 4044251
Rev Port Pneumol. 2012 Jul-Aug;18(4):190-3
pubmed: 22445256
J Dtsch Dermatol Ges. 2011 Sep;9(9):705-14; quiz 715
pubmed: 21722309
Eur J Epidemiol. 1985 Jun;1(2):150-2
pubmed: 3842361
J Bras Pneumol. 2007 May-Jun;33(3):295-300
pubmed: 17906791
J Eur Acad Dermatol Venereol. 2000 Mar;14(2):113-7
pubmed: 10972096
Acta Derm Venereol. 1996 Jan;76(1):84-5
pubmed: 8721509
Med Oral. 1997 Jan-Feb;2(1):39-43
pubmed: 11507456
Med Mycol. 2009 Dec;47(8):879-82
pubmed: 19184775
Diagn Cytopathol. 1996 Dec;15(5):442-6
pubmed: 8989552
Radiologia. 2011 Nov-Dec;53(6):560-3
pubmed: 21529860
Mycoses. 1988 Aug;31(8):395-403
pubmed: 3185607
Respiration. 2018;96(3):283-301
pubmed: 29953992
Thorax. 1986 Jan;41(1):72-3
pubmed: 3704971
Eur J Epidemiol. 1985 Sep;1(3):160-5
pubmed: 3842116
Future Microbiol. 2013 Sep;8(9):1177-91
pubmed: 24020744
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619894913
pubmed: 31840561
J Bras Pneumol. 2009 Dec;35(12):1245-9
pubmed: 20126928
Chest. 2017 Jan;151(1):e13-e16
pubmed: 28065255
Med Clin (Barc). 2005 Jun 4;125(1):39
pubmed: 15960947
J Travel Med. 2010 Mar-Apr;17(2):139-40
pubmed: 20412183
Enferm Infecc Microbiol Clin. 2010 Apr;28(4):259-60
pubmed: 19729228
Mycopathol Mycol Appl. 1964 Dec 21;24:265-70
pubmed: 14257108
Ann Otol Rhinol Laryngol. 2010 Feb;119(2):89-92
pubmed: 20336918
J Travel Med. 2020 Jul 14;27(4):
pubmed: 32043134
Clin Microbiol Rev. 1993 Apr;6(2):89-117
pubmed: 8472249
PLoS Negl Trop Dis. 2018 Feb 15;12(2):e0006245
pubmed: 29447170

Auteurs

Gernot Wagner (G)

Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Dr.-Karl-Dorrek-Strasse 30, 3500 Krems, Austria.

Deddo Moertl (D)

Clinical Department of Internal Medicine III, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, Dunant-Platz 1, 3100 St. Poelten, Austria.

Anna Glechner (A)

Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Dr.-Karl-Dorrek-Strasse 30, 3500 Krems, Austria.

Verena Mayr (V)

Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Dr.-Karl-Dorrek-Strasse 30, 3500 Krems, Austria.

Irma Klerings (I)

Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Dr.-Karl-Dorrek-Strasse 30, 3500 Krems, Austria.

Casey Zachariah (C)

Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Dr.-Karl-Dorrek-Strasse 30, 3500 Krems, Austria.

Miriam Van den Nest (M)

Department for Infection Control and Hospital Epidemiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

Gerald Gartlehner (G)

Department for Evidence-Based Medicine and Evaluation, Danube University Krems, Dr.-Karl-Dorrek-Strasse 30, 3500 Krems, Austria.
RTI International, 3040 East Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709-2194, USA.

Birgit Willinger (B)

Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

Classifications MeSH